| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00002030-200209060-00021 |
| P698 | PubMed publication ID | 12218400 |
| P50 | author | Harvey M. Friedman | Q89912954 |
| P2093 | author name string | James C Coyne | |
| Brian L Strom | |||
| Robert Gross | |||
| Warren B Bilker | |||
| P433 | issue | 13 | |
| P304 | page(s) | 1835-1837 | |
| P577 | publication date | 2002-09-01 | |
| P1433 | published in | AIDS | Q4651863 |
| P1476 | title | Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy | |
| P478 | volume | 16 |
| Q40551133 | A Comparison of Adherence Timeframes Using Missed Dose Items and Their Associations with Viral Load in Routine Clinical Care: Is Longer Better? |
| Q36416703 | Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE study |
| Q37587086 | Barriers and facilitators to engagement and retention in care among transgender women living with human immunodeficiency virus |
| Q80113545 | Can urine lamivudine be used to monitor antiretroviral treatment adherence? |
| Q37725129 | Cognitive and field testing of a new set of medication adherence self-report items for HIV care |
| Q33708071 | Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial |
| Q28610686 | Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada |
| Q36545143 | Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV. |
| Q35146085 | Factors associated with the accuracy of physicians' predictions of patient adherence |
| Q40330647 | HIV Provider Documentation and Actions Following Patient Reports of At-risk Behaviors and Conditions When Identified by a Web-Based Point-of-Care Assessment |
| Q36506174 | Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and Zambia |
| Q36263838 | Integrating a web-based, patient-administered assessment into primary care for HIV-infected adults |
| Q33393729 | Lack of association between retrospectively collected pharmacy refill data and electronic drug monitoring of antiretroviral adherence |
| Q94397641 | Measures of antiretroviral adherence for detecting viral non‐suppression in people living with HIV |
| Q39023695 | No room for complacency about adherence to antiretroviral therapy in sub-Saharan Africa. |
| Q33705650 | Patients' perspectives on informal caregiver involvement in HIV health care appointments |
| Q36248583 | Pharmacological pain control for human immunodeficiency virus-infected adults with a history of drug dependence |
| Q33827782 | Physician estimate of antiretroviral adherence in India: poor correlation with patient self-report and viral load |
| Q36628011 | Predictors of antiretroviral treatment failure in an urban HIV clinic |
| Q39727839 | Provider perceptions of the value of same-day, electronic patient-reported measures for use in clinical HIV care |
| Q33703513 | Provider-focused intervention increases adherence-related dialogue but does not improve antiretroviral therapy adherence in persons with HIV |
| Q36006322 | Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study |
| Q35008754 | Review article: adherence to medication for chronic hepatitis C - building on the model of human immunodeficiency virus antiretroviral adherence research |
| Q34056085 | Risk factors for nonadherence to warfarin: results from the IN-RANGE study |
| Q36338885 | The population effectiveness of highly active antiretroviral therapy: are good drugs good enough? |
| Q47586004 | Utilization of health care resources by HIV-infected white, African-American, and Hispanic men in the era before highly active antiretroviral therapy |
| Q34624904 | Validating five questions of antiretroviral nonadherence in a public-sector treatment program in rural South Africa |
| Q36174872 | When to initiate antiretroviral therapy in HIV-1-infected adults: a review for clinicians and patients |
| Q36823256 | Which Clinician Questions Elicit Accurate Disclosure of Antiretroviral Non-adherence When Talking to Patients? |
Search more.